Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists.

MLA

Sicras Mainar, Antoni, et al. “Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists.” Journal of Clinical Medicine, vol. 13, no. 21, Nov. 2024, p. 6495. EBSCOhost, https://doi.org/10.3390/jcm13216495.

APA

Sicras Mainar, A., Salazar-Mendiguchía, J., del Campo Alonso, M. I., Echeto, A., Vilanova Larena, D., & Comín Colet, J. (2024). Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists. Journal of Clinical Medicine, 13(21), 6495. https://doi.org/10.3390/jcm13216495

Chicago

Sicras Mainar, Antoni, Joel Salazar-Mendiguchía, María Isabel del Campo Alonso, Ainara Echeto, David Vilanova Larena, and Josep Comín Colet. 2024. “Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists.” Journal of Clinical Medicine 13 (21): 6495. doi:10.3390/jcm13216495.